Thursday, August 11, 2016 12:56:40 PM
According to today's article, the company is worth about 70 million. If the phase 3 study receives approval for CLI (a 14 billion dollar market), I will take 50% of that market for PSTI (7 billion) as there are practically no alternatives.
So, take the number of shares you own, and multiply that number of shares by $100- (7 billion market / 70 million net worth).
This is not like rolling the dice- we have the past data to make rationale decisions.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM